The clinical treatment target for HbA1c in Denmark for type 1 diabetes is ≤53 mmol/mol [1].

The table below shows HbA1c outcomes by region [2]. The data demonstrates that fewer than 25% of patients with type 1 diabetes achieve the goals for HbA1c.